CollPlant Biotechnologies Ltd. (CLGN)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Oct 09, 16:00
3.61
+0.10
(+2.85%)
After-Hours: 20:00
CollPlant Biotechnologies Max Drawdown (5Y) : 98.79% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.79% |
| August 31, 2026 | 98.79% |
| July 31, 2026 | 98.79% |
| June 30, 2026 | 98.70% |
| May 31, 2026 | 98.70% |
| April 30, 2026 | 98.70% |
| March 31, 2026 | 97.62% |
| February 28, 2026 | 97.49% |
| January 31, 2026 | 94.43% |
| December 31, 2025 | 94.43% |
| November 30, 2025 | 94.43% |
| October 31, 2025 | 94.43% |
| September 30, 2025 | 94.43% |
| August 31, 2025 | 94.43% |
| July 31, 2025 | 94.43% |
| June 30, 2025 | 94.39% |
| May 31, 2025 | 93.61% |
| April 30, 2025 | 91.75% |
| March 31, 2025 | 89.48% |
| February 28, 2025 | 86.56% |
| January 31, 2025 | 85.94% |
| December 31, 2024 | 85.94% |
| November 30, 2024 | 84.82% |
| October 31, 2024 | 85.46% |
| September 30, 2024 | 85.46% |
| Date | Value |
|---|---|
| August 31, 2024 | 85.96% |
| July 31, 2024 | 87.97% |
| June 30, 2024 | 87.97% |
| May 31, 2024 | 87.97% |
| April 30, 2024 | 87.97% |
| March 31, 2024 | 87.97% |
| February 29, 2024 | 87.97% |
| January 31, 2024 | 87.97% |
| December 31, 2023 | 87.97% |
| November 30, 2023 | 87.97% |
| October 31, 2023 | 87.97% |
| September 30, 2023 | 87.97% |
| August 31, 2023 | 87.97% |
| July 31, 2023 | 87.97% |
| June 30, 2023 | 87.97% |
| May 31, 2023 | 87.97% |
| April 30, 2023 | 87.97% |
| March 31, 2023 | 87.97% |
| February 28, 2023 | 87.97% |
| January 31, 2023 | 87.97% |
| December 31, 2022 | 87.97% |
| November 30, 2022 | 87.97% |
| October 31, 2022 | 87.97% |
| September 30, 2022 | 87.97% |
| August 31, 2022 | 87.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
| MiMedx Group, Inc. | 85.36% |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | 97.93% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.65 |
| Beta (5Y) | 0.7626 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 77.83% |
| Historical Sharpe Ratio (5Y) | -0.7326 |
| Historical Sortino (5Y) | -1.327 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.27% |